Shareholders That Lost Money on Cerevel Therapeutics Holdings, Inc. (ABBV) Should Contact Levi & Korsinsky about Pending Class Action - ABBVAccesswire • 04/29/25
RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)PRNewsWire • 04/29/25
Levi & Korsinsky Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBVPRNewsWire • 04/29/25
S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings ReportInvestopedia • 04/28/25
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. (ABBV) Urged to Join Class Action – Contact The Gross Law Firm to Learn MoreGlobeNewsWire • 04/28/25
Shareholders of Cerevel Therapeutics Holdings, Inc. Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - ABBVPRNewsWire • 04/28/25